Selected List of InterLink Assignments

• ASA Pharma PLC (Ireland): Raise capital from private investors and identify development and marketing partners in North America

• BASF (Germany): Development of a Biotechnology Strategy for applications in the biotechnology seed business

• BioMan S.r.l (Italy): Out-license key technology in North America

• Cerylid Biosciences Ltd (Australia): Divestiture of key technology assets

• Chile-Global (Chile): Technology assessment and technology brokerage

• CONICYT (Chile): Consulting services in technology evaluation

• Consejo Nacional de Innovacion (National Council for Innovation) Santiago, Chile:
  “National Biotechnology Assessment and Strategic Recommendations”
  “Establishment of Centers for Innovation Technology Transfer and Entrepreneurship (CITE) in Chile”

• Dekalb Genetics (Dekalb, IL): Technology assessment/due diligence in the acquisition of BioTechnica International Inc.
  Sale a portion of seed business assets

• Fundacion Chile (Chile): Consulting services in biotechnology strategy

• GenVitis S.A. (Chile) Created new company involved in grape biotechnology
  InterLink participates as an equity holder

• ENI-Euron (Milan, Italy): Biotechnology strategy for biofuels and biolubricants

• Fondazione Istituto Insubrico di Ricerca per la Vida (Geranzano, Italy) Provide accesss to HTS natural product library and microbial collection for pharmaceutical and biotechnology industries

• FemtoLink Biotechnologies LLC: Sale of BSE Prion Detection Patent Portfolio to ISTA S.p.A. Milan, Italy

• GAVISH Ltd. Galilee Bio Applications Ltd (Galilee Technology Center. Israel): Identify partners for product development and marketing in the fields of post-harvest technology and miniature, portable and automated DNA analysis device (SENSIS Ltd.)

• Immunovative Therapeutics, Inc. (Israel): Raise capital from private investors and strategic partners

• InGene Inc. (Taiwan): Assistance in obtaining FDA approval to produce transgenic enzyme as a feed additive in the USA

• Interlink Biotechnologies LLC (Auburn, CA):

  1. Sale of Peptides Patent Portfolio to VDDI Pharmaceuticals Inc. (Brentwood, TN)

  2. Sale of Microbial Collection to Smithkline Beecham (Madrid, Spain)

  3. Sale of Fungal Collection to Schering Plough (Kenilworth, NJ)

  4. Sale of Microbial Collection to Cetek Inc. (Marlborough, MA)

  5. Sale of Microbial Collection to Wyeth-Fort Dodge (Princeton, NJ)

  6. Provide access to microbial insecticidal proteins to Dow AgroSciences

  7. Provide access to microbial extracts as a source of new drugs to Novo Nordisk (Denmark)

• Interlink Biotechnologies LLC (Princeton, NJ): Sale of the company to a US based large pharmaceutical company

• IVS ISTA (Milan, Italy): Identify partners for corn breeding development and marketing in the US and Italy

• Limagrain Group (France): Strategic planning of technology and development of a comprehensive strategy for applications of biotechnology in Limagrain's seed and molecular farming business
  On behalf of Limagrain, approached US second largest seed company as an acquisition target

• Lucien Biotechnologies (Chile): Identify partners for technology development and marketing

• MedSonics Inc. (New York, NY): Raise capital from private investors

• Mycosynthetix Inc. (Chapel Hill, NC): Divestiture of key technology assets

• Montedison Group (Milan, Italy): Biotechnology Research and Development strategy for the sugar beet industry in the USA

• Multi-Client Study (Several pharmaceutical and biotechnology companies): World-Wide Resources for Bimolecular Screening

• Nascent Pharmaceuticals (San Francisco, CA): Raise capital from private investors and identify development and marketing partners

• Nissan Chemicals (Japan): Performed a technical and market assessment of new biocides and anti-biofilm agents

• Novartis (Switzerland): Acquisition of AgriTrading (Milan, Italy)

• Nuskin (Pharmanex) (Los Angeles, CA): Established capabilities in South America for the production of a nutraceutical

• Pharmacopia (Princeton, NJ): Performed a technical and marketing assessment of the role of combinatorial libraries in the development of new agricultural chemicals

• PhenoGenomics Corporation (Seattle, WA): Divestiture of key technology assets, raise capital from private investors and identify development partners

• Phytomedics Chile S.A. (Santiago, Chile) participated in the creation of a new company in the field of nutraceuticals in alliance with Phytomedics Inc. (USA), Rutgers University, University of Illinois and Fundacion Chile (Santiago, Chile)

• Provid Pharmaceuticals Inc. (Piscataway, NJ): Raise capital from private investors and identify development and marketing partners

• Philip Morris Europe (Switzerland): Biotechnology Strategy

• PhytoMyco Inc. (Greenvile, NC): Divestiture of key technology assets

• Sumitomo Chemicals-Valent USA (Walnut Creek, CA): Comprehensive study to assess the effect of transgenic crops in the company's agricultural chemical business
  Strategic recommendation

• Vitis Biosciences Inc. (Geneva, NY): Created new company involved in grape biotechnology
  InterLink participates as an equity holder and managing of the company.

• Yaupon Therapeutics Inc. (Philadelphia, PA): Raise capital from private investors and identify development and marketing partners.

Take the guesswork out of your technology strategy. Contact InterLink to get started.

© Copyright 2009 by Interlink Associates, LLC.